Beijing Municipal Science and Technology Commission
OrganisationROR
Trials
Collaborator, Phase 3, Active, not recruiting, 146 people, 9 Oct 2020
Collaborator, Phase 3, Status unknown, 430 people, 3 Nov 2015
Collaborator, Phase 4, Status unknown, 160 people, 31 Jul 2015
Collaborator, Phase 2/3, Completed, 675 people, 23 Jul 2015
Collaborator, Phase 2, Completed, 130 people, 17 Aug 2012
Collaborator, Phase 4, Completed, 204 people, 4 Jul 2012
Collaborator, Phase 2, Status unknown, 92 people, 30 Sept 2011
Collaborator, Phase 3, Status unknown, 400 people, 25 Nov 2009
Funded papers
A Facial Foundation Model for Clinical Biomarker Prediction and Real-World Mobile Deployment
Z211100003521022, 1 Oct 2026
Epigenetic training licenses naïve CD8+ T cell metabolic fitness and function
L232008, 18 Sept 2026
18 Sept 2026
No. Z181100001518005, 10 Sept 2026
Z241100009024056, 31 Aug 2026
D181100000218003, 31 Aug 2026
Z231100004823036, 20 Aug 2026
Z181100001518005, 12 Aug 2026
Expert consensus on the management of obesity in the elderly(2026 edition)
Z221100007422007, 11 Aug 2026
Z251100000725008, 26 Mar 2026
PhenoAge acceleration, serum tryptophan, and frailty in socially engaged actively aging elderly men
4 Mar 2026
Tetrachlorobisphenol A Induces Programmed Cell Death and Senescence in Vascular Endothelial Cells
Z191100006619094, 1 Feb 2026
Z181100001518005, 24 Nov 2025
7252230, 23 Sept 2025
Z181100001518005, 1 Sept 2025
Z200022, 24 May 2022
SIRT3 consolidates heterochromatin and counteracts senescence
Z191100001519005, 7 May 2021
Sources: pubmed.ncbi.nlm.nih.gov, api.crossref.org
Papers
Multidisciplinary care reduces frailty in older cardiac patients
Nature communications, 30 Sept 2026
ADA Scientific Sessions 2026 abstract, 5 Jun 2026
ADA Scientific Sessions 2026 abstract, 5 Jun 2026
The Risk Factor Changes for Diabetic Kidney in T2DM during 13-Year Period in Beijing Community
ADA Scientific Sessions 2025 abstract, 13 Jun 2025